| Genzyme Belgium | Genzyme Corporate | Search | Contact us | |||||||||
![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Fabry Disease – Cerebrovascular Complications Literature has documented that strokes and transient ischemic attacks are associated with Fabry disease. [1, 2] Thrombosis of small arteries thickened by the vascular accumulation of GL-3 lipids makes Fabry patients vulnerable to early ischemic stroke.[3] Thrombus formation may also be enhanced in Fabry disease due to adhesion of neutrophils and monocytes to endothelial cell walls.[4] Hypertension associated with renal dysfunction may also increase the risk for hemorrhagic stroke.[3] Other Fabry-related cerebrovascular signs and symptoms associated with Fabry disease may include:[1] References 2. Grewal RP. Stroke in Fabry's disease. J Neurol 1994;241:153-156. 3. Grewal RP, McLatchey SK. Cerebrovascular manifestations in a female carrier of Fabry's disease. Acta Neurol Belg. 1992;92:36-40. 4. DeGraba T, Azhar S, Dignat-George F, et al. Profile of endothelial and leukocyte activation in Fabry patients. Ann Neurol. 2000;47:229-233.
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Terms and Conditions of Use | Privacy Policy | © 2010 Genzyme Corporation. All rights reserved. | ![]() |
|